Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 91 AL 105

Protein-protein interaction network analysis for the identification of novel multi-target inhibitors and target miRNAs against Alzheimer's disease

Kumar V, Roy K.

Adv Protein Chem Struct Biol. 2024;139:405-467. doi: 10.1016/bs.apcsb.2023.11.005. Epub 2024 Feb 15.

Recent advances in the total synthesis of galantamine, a natural medicine for Alzheimer's disease

Cheng B, Wang Q, An Y, Chen F.

Nat Prod Rep. 2024 Jul 17;41(7):1060-1090. doi: 10.1039/d4np00001c.

Molecular hybridization: a powerful tool for multitarget drug discovery

de Sena Murteira Pinheiro P, Franco LS, Montagnoli TL, Fraga CAM.

Expert Opin Drug Discov. 2024 Apr;19(4):451-470. doi: 10.1080/17460441.2024.2322990. Epub 2024 Mar 8.

Nanotechnology-based delivery of therapeutics through the intranasal pathway and the blood-brain barrier for Alzheimer's disease treatment

Boyetey MB, Choi Y, Lee HY, Choi J.

Biomater Sci. 2024 Apr 16;12(8):2007-2018. doi: 10.1039/d3bm02003g.

Involvement of mitochondria in Alzheimer's disease pathogenesis and their potential as targets for phytotherapeutics

Maruthiyodan S, Mumbrekar KD, Guruprasad KP.

Mitochondrion. 2024 May;76:101868. doi: 10.1016/j.mito.2024.101868. Epub 2024 Mar 9.

Resveratrol: Protective Agent Against Alzheimer's Disease

Subhan I, Siddique YH.

Cent Nerv Syst Agents Med Chem. 2024;24(3):249-263. doi: 10.2174/0118715249287167240222081517.

Drug Design for Alzheimer's Disease: Biologics vs. Small Molecules

Weaver DF.

Curr Alzheimer Res. 2024;20(12):821-826. doi: 10.2174/0115672050301583240307114452.

Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial

Howard R, Cort E, Rawlinson C, Wiegand M, Downey A, Lawrence V, Banerjee S, Bentham P, Fox C, Harwood R, Hunter R, Livingston G, Moniz-Cook E, Panca M, Raczek M, Ivenso C, Russell G, Thomas A, Wilkinson P, Freemantle N, Gould R.

Alzheimers Dement. 2024 Apr;20(4):2990-2999. doi: 10.1002/alz.13766. Epub 2024 Mar 13.

Lecanemab Questions

Nadeau SE.

Neurology. 2024 Apr 9;102(7):e209320. doi: 10.1212/WNL.0000000000209320. Epub 2024 Mar 14.

A review of the advances, insights, and prospects of gene therapy for Alzheimer's disease: A novel target for therapeutic medicine

Ataei B, Hokmabadi M, Asadi S, Asadifard E, Aghaei Zarch SM, Najafi S, Bagheri-Mohammadi S.

Gene. 2024 Jun 20;912:148368. doi: 10.1016/j.gene.2024.148368. Epub 2024 Mar 12.

Role of Cytoskeletal Elements in Regulation of Synaptic Functions: Implications Toward Alzheimer's Disease and Phytochemicals-Based Interventions

Verma H, Kaur S, Kaur S, Gangwar P, Dhiman M, Mantha AK.

Mol Neurobiol. 2024 Oct;61(10):8320-8343. doi: 10.1007/s12035-024-04053-3. Epub 2024 Mar 16.

Alzheimer's disease and clinical trials

Paul D, Agrawal R, Singh S.

J Basic Clin Physiol Pharmacol. 2024 Mar 18;35(1-2):31-44. doi: 10.1515/jbcpp-2023-0264. eCollection 2024 Jan 1.

Benzimidazole and Benzoxazole Derivatives Against Alzheimer's Disease

Faydalı N, Arpacı ÖT.

Chem Biodivers. 2024 Jun;21(6):e202400123. doi: 10.1002/cbdv.202400123. Epub 2024 Apr 27.

Gut microbiota and its metabolites in Alzheimer's disease: from pathogenesis to treatment

Zou X, Zou G, Zou X, Wang K, Chen Z.

PeerJ. 2024 Mar 13;12:e17061. doi: 10.7717/peerj.17061. eCollection 2024.

Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer's disease

Albadrani HM, Chauhan P, Ashique S, Babu MA, Iqbal D, Almutary AG, Abomughaid MM, Kamal M, Paiva-Santos AC, Alsaweed M, Hamed M, Sachdeva P, Dewanjee S, Jha SK, Ojha S, Slama P, Jha NK.

Biomed Pharmacother. 2024 May;174:116376. doi: 10.1016/j.biopha.2024.116376. Epub 2024 Mar 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias